Internal Medicine, Infectious Disease · Saddle Brook, NJ
NPI
1740271998
Since 2005
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
289 Market St, Suite 2
Saddle Brook, NJ, 07663
Phone (201) 587-9204
Groups this clinician bills Medicare through
Medicare paid, 2024
$146K
2,493 services
Medicare patients, 2024
205
Average age 75
Drug cost, 2024
$2.5M
1,590 prescriptions
Company payments, 2025
$2,447
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald J Poblete was code 99232 (hospital e&m - subsequent), 1,671 times for 128 patients. In total Ronald J Poblete billed 2,493 services in 13 codes, and Medicare paid $146K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,671 | 128 | $66.28 | $111K |
| 99223 Hospital E&M - Initial | Facility | 160 | 156 | $143.01 | $23K |
| 99214 Office E&M - Established | Office | 38 | 18 | $60.53 | $2,300 |
By year: 2022 $107K for 1,398 services; 2023 $136K for 1,843 services; 2024 $146K for 2,493 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald J Poblete prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 208 prescriptions and refills. In total Ronald J Poblete wrote 1,590 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 208 | 210 | 27 | $804K |
| Juluca Dolutegravir/Rilpivirine | 185 | 191 | 17 | $647K |
| Dovato Dolutegravir Sodium/Lamivudine | 103 | 109 | 13 | $312K |
| Amlodipine Besylate Generic | 90 | 143 | 17 | $267 |
| Atorvastatin Calcium Generic | 68 | 106 | 17 | $381 |
| Losartan Potassium Generic | 67 | 115 | 14 | $367 |
| Tivicay Dolutegravir Sodium | 61 | 61 | Under 11 | $134K |
| Ritonavir Generic | 51 | 51 | Under 11 | $5,682 |
| Metformin Hcl Generic | 47 | 53 | Under 11 | $160 |
| Darunavir Generic | 38 | 38 | Under 11 | $24K |
| Descovy Emtricitabine/Tenofov Alafenam | 33 | 33 | Under 11 | $71K |
| Rosuvastatin Calcium Generic | 27 | 39 | Under 11 | $73.42 |
| Vancomycin Hcl Generic | 23 | 23 | Under 11 | $1,852 |
| Metoprolol Succinate Generic | 23 | 35 | Under 11 | $108 |
| Pifeltro Doravirine | 23 | 25 | Under 11 | $43K |
Brand drugs: 737 claims; generic drugs: 853 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald J Poblete $2,447 ($2,447 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $1,023.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.